For patients with metastatic disease, the standard first-line treatment approach is a combination of 5-fluorouracil (5FU)/platinum chemotherapy along with trastuzumab for tumors that are positive for human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is metastatic neoplasm.